Mark Mlotek - Henry Schein Chief VP
| HS2 Stock | EUR 66.06 1.76 2.60% |
Insider
Mark Mlotek is Chief VP of Henry Schein
| Age | 67 |
| Phone | 631 843 5500 |
| Web | https://www.henryschein.com |
Henry Schein Management Efficiency
The company has return on total asset (ROA) of 0.0642 % which means that it generated a profit of $0.0642 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1211 %, meaning that it generated $0.1211 on every $100 dollars invested by stockholders. Henry Schein's management efficiency ratios could be used to measure how well Henry Schein manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Dave Lardy | Patterson Companies | N/A | |
| Yijian Wu | Sinopharm Group Co | 53 | |
| Andrea Frohning | Patterson Companies | 53 | |
| PharmD Mauch | AmerisourceBergen | 56 | |
| Paul Guggenheim | Patterson Companies | 63 | |
| Steven Collis | AmerisourceBergen | 62 | |
| Shui ACS | Shanghai Pharmaceuticals Holdin | 46 | |
| Ola Snow | Cardinal Health | 55 | |
| Deborah Weitzman | Cardinal Health | N/A | |
| John Wright | Patterson Companies | N/A | |
| Adel Mekhail | Prestige Consumer Healthcare | 62 | |
| Gina Clark | AmerisourceBergen | 66 | |
| Michelle Greene | Cardinal Health | N/A | |
| Qingming Yu | Sinopharm Group Co | 59 | |
| Jason Hollar | Cardinal Health | 50 | |
| Yong Liu | Sinopharm Group Co | 54 | |
| Shivani Kaul | Patterson Companies | N/A | |
| Dean Siegal | Prestige Consumer Healthcare | N/A | |
| Xiaojuan Li | Sinopharm Group Co | 47 | |
| Haoliang Gu | Shanghai Pharmaceuticals Holdin | 57 | |
| Shunjiang Yu | Shanghai Pharmaceuticals Holdin | N/A | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0642 |
Henry Schein Leadership Team
Elected by the shareholders, the Henry Schein's board of directors comprises two types of representatives: Henry Schein inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Henry. The board's role is to monitor Henry Schein's management team and ensure that shareholders' interests are well served. Henry Schein's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Henry Schein's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Ettinger, Ex COO | ||
| Walter Siegel, VP Officer | ||
| Graham Stanley, VP Officer | ||
| Stanley Bergman, Ex CEO | ||
| Steven Paladino, Ex Director | ||
| Ronald South, VP CFO | ||
| Mark Mlotek, Chief VP | ||
| Olga Timoshkina, Chief Fin | ||
| Christopher Pendergast, VP CTO | ||
| James Breslawski, Ex Pres |
Henry Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Henry Schein a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0642 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 11.9 B | |||
| Shares Outstanding | 131.28 M | |||
| Shares Owned By Insiders | 1.01 % | |||
| Shares Owned By Institutions | 98.99 % | |||
| Price To Earning | 16.81 X | |||
| Price To Book | 3.09 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Henry Stock
When determining whether Henry Schein offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Henry Schein's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Henry Schein Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Henry Schein Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Henry Schein. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Henry Stock please use our How to Invest in Henry Schein guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.